Ito Y - Search Results

1

A case of endocapillary proliferative glomerulonephritis with macrophages phagocytosing monoclonal immunoglobulin lambda light chain.

Watanabe H, Osawa Y, Goto S, Habuka M, Imai N, Ito Y, Hirose T, Chou T, Ohashi R, Shimizu A, Ehara T, Shimotori T, Narita I. Watanabe H, et al. Among authors: ito y. Pathol Int. 2015 Jan;65(1):38-42. doi: 10.1111/pin.12229. Epub 2014 Nov 19. Pathol Int. 2015. PMID: 25410550

2

Intact PTH assay overestimates true 1-84 PTH levels after maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism.

Kazama JJ, Omori K, Higuchi N, Takahashi N, Ito Y, Maruyama H, Narita I, Cantor TL, Gao P, Gejyo F. Kazama JJ, et al. Among authors: ito y. Nephrol Dial Transplant. 2004 Apr;19(4):892-7. doi: 10.1093/ndt/gfh038. Nephrol Dial Transplant. 2004. PMID: 15031346

3

The role of lymphocytes in the experimental progressive glomerulonephritis.

Ikezumi Y, Kanno K, Karasawa T, Han GD, Ito Y, Koike H, Toyabe S, Uchiyama M, Shimizu F, Kawachi H. Ikezumi Y, et al. Among authors: ito y. Kidney Int. 2004 Sep;66(3):1036-48. doi: 10.1111/j.1523-1755.2004.00852.x. Kidney Int. 2004. PMID: 15327397 Free article.

4

Pretreatment plasma intact parathyroid hormone and serum calcium levels, but not serum phosphate levels, predict the response to maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism.

Oyama Y, Kazama JJ, Omori K, Higuchi N, Kameda S, Yamamoto S, Ito Y, Maruyama H, Narita I, Gejyo F. Oyama Y, et al. Among authors: ito y. Clin Exp Nephrol. 2005 Jun;9(2):142-7. doi: 10.1007/s10157-005-0342-2. Clin Exp Nephrol. 2005. PMID: 15980949 Clinical Trial.

5

Abeta-2M-amyloidosis and related bone diseases.

Kazama JJ, Yamamoto S, Takahashi N, Ito Y, Maruyama H, Narita I, Gejyo F. Kazama JJ, et al. Among authors: ito y. J Bone Miner Metab. 2006;24(2):182-4. doi: 10.1007/s00774-005-0669-5. J Bone Miner Metab. 2006. PMID: 16502130 Review.

6

Circulating osteoprotegerin affects bone metabolism in dialysis patients with mild secondary hyperparathyroidism.

Kazama JJ, Omori K, Yamamoto S, Ito Y, Maruyama H, Narita I, Gejyo F, Iwasaki Y, Fukagawa M. Kazama JJ, et al. Among authors: ito y. Ther Apher Dial. 2006 Jun;10(3):262-6. doi: 10.1111/j.1744-9987.2006.00375.x. Ther Apher Dial. 2006. PMID: 16817791

7

Alterations in serum phosphate levels predict the long-term response to intravenous calcitriol therapy in dialysis patients with secondary hyperparathyroidism.

Hosaka K, Kazama JJ, Yamamoto S, Ito Y, Iino N, Maruyama H, Saito A, Narita I, Gejyo F. Hosaka K, et al. Among authors: ito y. J Bone Miner Metab. 2008;26(2):185-90. doi: 10.1007/s00774-007-0809-1. Epub 2008 Feb 27. J Bone Miner Metab. 2008. PMID: 18301976 Clinical Trial.

8

Two distinct FSGS lesions caused by distinct etiology confirmed in a single patient in pre- and post-transplantation.

Ito Y, Nishi S, Imai N, Narita I, Gejyo F, Saito K, Nakagawa Y, Tasaki M, Takahashi K. Ito Y, et al. Clin Transplant. 2010 Jul;24 Suppl 22:54-9. doi: 10.1111/j.1399-0012.2010.01267.x. Clin Transplant. 2010. PMID: 20590696

9

The case of BK virus infection in which it was difficult to differentiate from acute rejection.

Ito Y, Nishi S, Imai N, Yoshita K, Saito K, Nakagawa Y, Takahashi K, Narita I. Ito Y, et al. Clin Transplant. 2011 Jul;25 Suppl 23:44-8. doi: 10.1111/j.1399-0012.2011.01481.x. Clin Transplant. 2011. PMID: 21623914

10

Clinicopathological findings of immunoglobulin G4-related kidney disease.

Nishi S, Imai N, Yoshida K, Ito Y, Saeki T. Nishi S, et al. Among authors: ito y. Clin Exp Nephrol. 2011 Dec;15(6):810-9. doi: 10.1007/s10157-011-0526-x. Epub 2011 Aug 26. Clin Exp Nephrol. 2011. PMID: 21870078 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,178 results

Search Page

Filters